Prostate cancer is the most common cancer and the second-leading cause of death among men in the United States. It is associated with significant clinical and economic burden. This supplement to The American Journal of Managed Care is intended to provide a clinical understanding of prostate cancer, discuss current, new, and evolving treatment strategies for early-stage, recurrent, and advanced prostate cancer, and discuss the economic burden of the disease.Faculty
Robert Dreicer, MD, MS, FACP, FASCO
Director, GU Medical Oncology
Taussig Cancer Institute
Cleveland Clinic
Cleveland, Ohio
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Cleveland, Ohio
Deputy Associate Director of Clinical Research
Case Comprehensive Cancer Center
Cleveland, Ohio
Michael Kolodziej, MD, FACP
National Medical Director
Oncology Solutions
Aetna
Hartford, Connecticut
Neal Shore, MD, FACS
Medical Director
Carolina Urologic Research Center (CURC)
Atlantic Urology Clinics
Myrtle Beach, South Carolina
Editorial Support
Paige Davies, PhD
Hitt Medical Writing, LLC
Alpharetta, Georgia
Emma Nichols, PhD
Hitt Medical Writing, LLC
Alpharetta, Georgia
Kim Tran-Kerr, MD
Hitt Medical Writing, LLC
Alpharetta, Georgia
Faculty Disclosures
Robert Dreicer, MD, MS, FACP, FASCO, has disclosed the following relevant commercial financial relationships or affiliations in the past 12 months:
Consultant:
Astellas Pharma, Janssen Pharmaceuticals, Inc, Medivation, Inc, Merck, Millennium Pharmaceuticals, Inc, Roche
Honoraria: Astellas Pharma
Michael Kolodziej, MD, FACP, has disclosed the following relevant commercial financial relationships or affiliations in the past 12 months:
Stock/shareholder: Aetna
Neal Shore, MD, FACS, has no relevant financial relationships with commercial interests to disclose.
Editorial Support
Paige Davies, PhD; Emma Nichols, PhD; and Kim Tran-Kerr, MD, have no relevant financial relationships with commercial interests to disclose.
The American Journal of Managed Care
Publishing Staff—Jeff D. Prescott, PharmD, RPh; Ida Delmendo; and Tara Petersen have no relevant financial relationships with commercial interests to disclose.
University of Cincinnati
Planning staff—Susan P. Tyler, MEd, CMP, CCMEP, Director, University of Cincinnati, has no relevant
financial relationships with commercial interests to disclose.
CME Physician Reviewer—Rick Ricer, MD, University of Cincinnati, has no relevant financial relationships
with commercial interests to disclose.
Pharmacy Times Office of Continuing Professional Education
Planning staff—David Heckard; Steve Lin, PharmD, RPh; Donna Fausak; and Nathalie Harden have no relevant financial relationships with commercial interests to disclose.